DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on May 12, 2008; DOI: 10.1124/dmd.108.020560


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.108.020560v1
36/8/1562    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, H.-X.
Right arrow Articles by Yang, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, H.-X.
Right arrow Articles by Yang, L.


Received for publication March 4, 2008.
Revised May 8, 2008.
Accepted for publication May 9, 2008.

UDP-Glucuronosyltransferase 1A6 Is the Major Isozyme Responsible for Protocatechuic Aldehyde Glucuronidation in Human Liver Microsomes

Hui-Xin Liu 1, Yong Liu 1, Jiang-Wei Zhang 1, Wei Li 1, Hong-Tao Liu 1, Ling Yang 1*

1 Dalian Institute of Chemical Physics, The Chinese Academy of Sciences

* Address correspondence to: E-mail: yling{at}dicp.ac.cn

Abstract

Glucuronidation is an important pathway in the metabolism of protocatechuic aldehyde (3,4-dihydroxybenzaldehyde, PAL). However, the metabolites and primary UDP-glucuronosyltransferase (UGT) isozymes responsible for PAL glucuronidation remain to be determined in human. Here, we characterized PAL glucuronidation by human liver micorsomes (HLMs), human intestine microsomes (HIMs) and 12 recombinant UGT (rUGT) isozymes to identify what kinds of metabolites are and which human UGT isozymes involved. Two metabolites (M-1 and M-2) were detected in reactions catalyzed by HLMs, HIMs, rUGT1A6 and rUGT1A9, and identified as mono-glucuronides by LC-MS. A kinetic study showed that PAL glucuronidation by rUGT1A6, rUGT1A9, HIMs, and HLMs followed Michaelis-Menten kinetics. The Km values of HLMs, HIMs, rUGT1A6 and rUGT1A9 for PAL glucuronidation were as follows: 432.7 ± 24.5, 626.9 ± 49.2, 367.5 ± 25.1 and 379.9 ± 42.5 µM for M-1; 336.7 ± 15.3, 494.3 ± 48.7, 211.4 ± 13.4, and 238.5 ± 26.2 µM for M-2, respectively. The PAL glucuronidation activity was significantly correlated with UGT1A6 activity rather than UGT1A9 activity from 15 individual HLMs. Chemical inhibition studies showed that the IC50 for phenylbutazone inhibition of PAL glucuronidation was similar in HLMs (61.9 ± 7.9 µM) compared with rUGT1A6 (45.3 ± 7.7 µM). In contrast, androsterone inhibited rUGT1A9-catalyzed and HLMs-catalyzed PAL glucuronidation with IC50 values of 27.1 ± 3.8 µM and >500 µM, respectively. In combination, we identified UGT1A6 was the major isozyme responsible for PAL glucuronidation in HLMs.


Key words: liver microsomes, phase II drug metabolism, UDP glucuronyltransferases





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.